Sign in
Download Opera News App

News Politics




European politics

Johnson and Johnson have looking for emergency authorization from FDA

Johnson and Johnson ask the FDA to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated American. The FDA's Vaccine and Related Biological products Advisory Committee is scheduled to meet October 14 and 15 to consider request from Mordena and Johnson & Johnson to add booster doses for their COVID-19 vaccine.

The boosting Janseem's vaccine two months after the first shot increased antibody response fourfold, the company said, and was associated in real life with 94% effectiveness. You've to waiting until six months to boost increase antibody protection 12-fold, the company said last month.

The Johnson and Johnson booster shot prompts large increase in immune response, company say. Pfizer received the FDA's OK last month for booster doses six months ago or longer.

In asking for FDA authorization for a booster, Pfizer present data showing vaccine efficacy was waning over time. Mammen said that doesn't happen with janseen's shot.

Content created and supplied by: Lidokuhle19 (via Opera News )

FDA Janseem Johnson and Johnson Mammen Pfizer


Load app to read more comments